transfer agency and registrar services agreementTransfer Agency and Registrar Services Agreement • January 16th, 2020 • Scopus BioPharma Inc. • Pharmaceutical preparations • New York
Contract Type FiledJanuary 16th, 2020 Company Industry JurisdictionThis Transfer Agency and Registrar Services Agreement (this “Agreement”), dated as of July 24, 2019 is between Scopus BioPharma Inc., a Delaware corporation (the “Company”) and Continental Stock Transfer & Trust Company, a New York limited purpose trust company (“CST”).
ContractWarrant Agreement • January 16th, 2020 • Scopus BioPharma Inc. • Pharmaceutical preparations
Contract Type FiledJanuary 16th, 2020 Company IndustryNumber WW INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE SERIES W WARRANTS CUSIP 809171 11 9 THIS SERIES A WARRANT SHALL BE VOID IF NOT EXERCISED PRIOR TO THE EXPIRATION OF THE EXERCISE PERIOD PROVIDED FOR IN THE WARRANT AGREEMENT DESCRIBED BELOW This certifies that______________________________________, or registered assigns, is the registered holder of _______________ Series W Warrants (“Series W Warrants” and each a “Series W Warrant” to purchase Series B Units, each a “Series B Unit”). Each Series W Warrant entitles the holder, upon exercise during the Exercise Period set forth in the Warrant Agreement referred to below, to receive from Scopus BioPharma Inc. (the “Company”) a Series B Unit consisting of one share of $0.001 par value common stock (‘Common Stock”) of the Company and one Series Z Warrant exercisable for one share of Common Stock at the exercise price determined pursuant to the Warrant Agreement, payable in lawful money (or through “cashless exercise” as provided
WARRANT AGREEMENT between SCOPUS BIOPHARMA INC. and CONTINENTAL STOCK TRANSFER & TRUST COMPANYWarrant Agreement • January 16th, 2020 • Scopus BioPharma Inc. • Pharmaceutical preparations • New York
Contract Type FiledJanuary 16th, 2020 Company Industry JurisdictionThis Series W and Series Z Warrant Agreement (“Agreement”) made as of ___________ __, 2020, by and between Scopus BioPharma Inc., a Delaware corporation, with offices at 420 Lexington Avenue, Suite 300, New York, New York 10170 (“Company”), and Continental Stock Transfer & Trust Company, a New York corporation, with offices at 1 State Street, 30th Floor, New York, New York 10004 (“Warrant Agent”).
SUBSCRIPTION AGREEMENTSubscription Agreement • January 16th, 2020 • Scopus BioPharma Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJanuary 16th, 2020 Company Industry Jurisdiction